Raymond James Financial Services Advisors, Inc. Tarsus Pharmaceuticals, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 10,362 shares of TARS stock, worth $451,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,362
Previous 13,026
20.45%
Holding current value
$451,265
Previous $354,000
3.95%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
40.5MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$142 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$141 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$110 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$109 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$98.2 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.16B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...